Severe Sepsis Clinical Trial
— EIDECSOfficial title:
A Time-series Intervention Analysis of End-of-life Decision-making in Patients With Sepsis-related Organ Failure
Verified date | August 2017 |
Source | Center for Sepsis Control and Care, Germany |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The care of patients with sepsis-related organ failure on the intensive care unit (ICU) often
includes end-of-life decision (EOL-D) and communication of such decisions to relatives. This
increases the psychological burden for caregiver and relatives.
The investigators intend to assess the prevalence and impact of EOL-D on ICU care-givers and
relatives ("before") and to use this data to develop and implement standard operating
procedures (SOPs) for improved decision-making and communication of these decisions
("after").
The hypothesis is that an improved communication strategy will reduce symptoms of burnout in
caregivers and symptoms of anxiety and depression in relatives.
Status | Completed |
Enrollment | 174 |
Est. completion date | September 30, 2014 |
Est. primary completion date | September 30, 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Staff: Inclusion Criteria: - all physicians and nursing staff who treat patients with sepsis-related organ failure on participating ICUs who consent to participate Exclusion Criteria: - Decline to participate Relatives: - Relatives of patients with sepsis-related organ failure and EOL-D who consent to participate Exclusion Criteria: - Decline to participate |
Country | Name | City | State |
---|---|---|---|
Germany | Jena University Hospital | Jena | Thuringia |
Lead Sponsor | Collaborator |
---|---|
Center for Sepsis Control and Care, Germany | German Federal Ministry of Education and Research |
Germany,
Embriaco N, Papazian L, Kentish-Barnes N, Pochard F, Azoulay E. Burnout syndrome among critical care healthcare workers. Curr Opin Crit Care. 2007 Oct;13(5):482-8. Review. — View Citation
Hartog CS, Schwarzkopf D, Riedemann NC, Pfeifer R, Guenther A, Egerland K, Sprung CL, Hoyer H, Gensichen J, Reinhart K. End-of-life care in the intensive care unit: a patient-based questionnaire of intensive care unit staff perception and relatives' psych — View Citation
Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C, Choukroun G, Curtis JR, Fieux F, Galliot R, Garrouste-Orgeas M, Georges H, Goldgran-Toledano D, Jourdain M, Loubert G, Reignier J, Saidi F, Souweine B, Vincent F, Barnes NK, Pochard F, Schlemmer B, Azoulay E. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007 Feb 1;356(5):469-78. Erratum in: N Engl J Med. 2007 Jul 12;357(2):203. — View Citation
Schwarzkopf D, Westermann I, Skupin H, Riedemann NC, Reinhart K, Pfeifer R, Fritzenwanger M, Günther A, Witte OW, Hartog CS. A novel questionnaire to measure staff perception of end-of-life decision making in the intensive care unit--development and psych — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Symptoms of burnout by MBI score in ICU caregivers | once during observation period (1 year) | ||
Primary | Symptoms of post-traumatic stress disorder by IES and HADS scores in relatives at 90 days | once during observation period (1 year) | ||
Secondary | Psychological symptoms by IES, HADS or MBI subscales in caregivers or relatives, respectively | once during the observation period (1 year) | ||
Secondary | Characteristics of patients with and without end-of-life decisions (EOL-D) including time periods (time until EOL-D, time between EOL-D until death or discharge) and 28-day and 90-day mortality rates | until death or discharge from the ICU | ||
Secondary | Prevalence and characteristics of EOL-D | until death or discharge from the ICU | ||
Secondary | Prevalence and characteristics of patients' advance directives | until death or discharge from the ICU | ||
Secondary | characteristics of EOL-D communication with relatives | ICU stay | ||
Secondary | Prevalence of request for "Ethik Konsil" (counseling by an external ethical review board) | until death or discharge from the ICU | ||
Secondary | direct costs of treatment of survivors and non-survivors | until death or discharge from the ICU |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Completed |
NCT02539147 -
Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis
|
N/A | |
Completed |
NCT01932814 -
Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful?
|
N/A | |
Completed |
NCT01929772 -
German Lactat Clearance in Severe Sepsis
|
N/A | |
Completed |
NCT01449721 -
Preemptive Resuscitation for Eradication of Septic Shock
|
N/A | |
Active, not recruiting |
NCT01162109 -
Zinc Therapy in Critical Illness
|
Phase 1 | |
Not yet recruiting |
NCT01211899 -
4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock
|
N/A | |
Completed |
NCT00934011 -
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
|
N/A | |
Recruiting |
NCT00335907 -
Protocol-driven Hemodynamic Support for Patients With Septic Shock
|
N/A | |
Completed |
NCT00463645 -
Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients
|
N/A | |
Completed |
NCT02361528 -
GM-CSF to Decrease ICU Acquired Infections
|
Phase 3 | |
Completed |
NCT02734550 -
(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis
|
N/A | |
Completed |
NCT02973243 -
The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III
|
N/A | |
Terminated |
NCT03895853 -
Early Metabolic Resuscitation for Septic Shock
|
Phase 2 | |
Completed |
NCT01945983 -
Early Use of Norepinephrine in Septic Shock Resuscitation
|
N/A | |
Completed |
NCT01598831 -
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
|
Phase 3 | |
Enrolling by invitation |
NCT02258984 -
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
|
N/A |